Position in CLDX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$258,422
+$258,422 QoQ
Shares Held
8,147
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Sep 30, 2025CallValue
$152,633
CallShares
5,900
PutValue
$77,610
PutShares
3,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in CLDX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $258,422 | 8,147 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $152,633 | 5,900 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $77,610 | 3,000 | Put | Sole | 2025-11-14 | |
| 2025-03-31 | $30,855 | 1,700 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $1,693,885 | 93,327 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $336,791 | 9,100 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $1,857,272 | 50,183 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $162,844 | 4,400 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $130,107 | 3,100 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $43,480 | 1,036 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $62,955 | 1,500 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $539,376 | 13,600 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $269,688 | 6,800 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $6,713,168 | 169,268 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $88,064 | 3,200 | Call | Sole | 2023-11-21 | |
| 2023-09-30 | $4,375,487 | 158,993 | Shares | Sole | 2023-11-21 | |
| 2023-09-30 | $22,016 | 800 | Put | Sole | 2023-11-21 | |
| 2023-06-30 | $37,323 | 1,100 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $6,786 | 200 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $4,114,080 | 121,252 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,511,979 | 69,816 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,800,573 | 85,272 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $13,371 | 300 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $17,828 | 400 | Put | Sole | 2023-02-14 | |
| 2022-09-30 | $4,832,165 | 171,902 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $1,273,196 | 37,381 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $549,731 | 14,227 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||